Mitral leaflet tethering

Information

  • Patent Grant
  • 12318296
  • Patent Number
    12,318,296
  • Date Filed
    Thursday, June 15, 2023
    a year ago
  • Date Issued
    Tuesday, June 3, 2025
    8 days ago
Abstract
This disclosure includes apparatuses and techniques to access the right ventricle via trans-femoral vein threading a catheter or catheters to the apex or bottom of the right ventricle. Piercing through the venous or right side of the heart in the interventricular septal wall to access the left ventricle a catheter can be passed to turn upward pointing to the mitral valve. From this access point in the left ventricle the flail mitral leaflet can be sutured and tethered pulling it back into position and reattached with a grounding anchor in the right ventricle or imbedding the anchor into the septal wall. The interventricular septal wall crossing technique could include the passing of a coaxial catheter through the first access catheter where the first access catheter could act as a guide to direct the internal or second coaxial catheter toward the flail mitral leaflet.
Description
BACKGROUND
Field

The disclosure relates generally to cardiac treatment devices and techniques, and in particular, to methods and devices for mitral valve repair.


Description of the Related Art

The heart includes four heart valves, which allow blood to pass through the four chambers of the heart in one direction. The four valves are the tricuspid, mitral, pulmonary and aortic valves. The four chambers are the right and left atria (upper chambers) and right and left ventricle (lower chambers).


The mitral valve is formed by two leaflets, which are known as the anterior leaflet and the posterior leaflet, which open and close in response to pressure placed on the leaflets by the pumping of the heart. There are several problems that can develop or occur with respect to the mitral valve. Such problems include mitral valve regurgitation (MR), in which the mitral valve leaflets do not close properly, which can cause leakage of the mitral valve. Severe mitral regurgitation can adversely affect cardiac function and compromise a patient's quality of life and life-span. There are several techniques directed to correcting mitral valve regurgitation, which include valve replacement, chordae tendinea shortening or replacement and mitral annular repair also known as annuloplasty.


Current techniques to correct mitral regurgitation include repairing the mitral valve via open heart surgery while a patient's heart is stopped and the patient is on cardiopulmonary bypass. Such techniques are highly invasive that have inherent risks. It would be desirable to provide a less invasive procedure for repairing a mitral valve.


SUMMARY

One embodiment disclosed herein includes a method of repairing a mitral valve of a patient's heart that comprises accessing a right ventricle of the patient's heart with a catheter extending through a venous or right side of the heart to access the left ventricle and and with the catheter securing a mitral valve leaflet.


Another embodiment disclosed herein is a chordae replacement system that can include a catheter and a chordae replacement implant. The catheter can have an elongate, flexible tubular body with a proximal end and a distal end. The catheter can be configured for transvascular access into the right ventricle, through the intraventricular septum and into the left ventricle. The chordae replacement implant can be deployably carried by the catheter. The chordae replacement implant can comprise an elongate body having a proximal end with a proximal tissue anchor and a distal end with a mitral valve leaflet attachment anchor.


Another embodiment disclosed herein is method of repairing a mitral valve, the method comprising with a catheter transvascularly accessing the right ventricle and extending the catheter through the intraventricular septum and into the left ventricle and deploying a chordae replacement implant with the catheter.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1AA illustrates the normal mitral leaflet connections in the left ventricle include chordal attachments from the free margin of the mitral leaflet to the papillary muscles.



FIG. 1A illustrates a ruptured chordal attachment.



FIG. 1 illustrates a technique to access the right ventricle via trans-femoral vein threading a catheter or catheters to the apex or bottom of the right ventricle.



FIG. 2 illustrates a catheter piercing through the venous or right side of the heart in the interventricular septal wall to access the left ventricle.



FIG. 3 illustrates first and second catheters that could be steered to position the distal tip to capture the margin of the mitral leaflet.



FIG. 4 illustrates magnets that can be used to position the tips of two catheters relative to one another.



FIG. 4A illustrates passing a suture loop through the mitral leaflet and tethered back through a lower catheter and attached to the anchor at the apex or intraventricular septal wall.



FIG. 5 illustrates a grounding plug.



FIG. 5A illustrates an internal anchor within the tissue wall separating the left and right ventricle or interventricular septal wall tissue.



FIG. 5AA illustrates a septal anchor



FIG. 5B illustrate embodiments of an internal anchor and apex anchor.



FIG. 6 illustrates a grounding anchor positioned within the heart.



FIG. 7 illustrates a coiled anchor.



FIG. 8 illustrates access from the jugular vein would also provide access into the vena cava and right ventricle and or access into the left atrium via trans-septal puncture.





DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

Normal mitral leaflet 10 connections in the left ventricle include chordal attachments 12 from the free margin of the mitral leaflet 10 to the papillary muscles 14, which are shown in FIG. 1AA


The repair and reconnection of a flail leaflet (a ruptured chord 7 being shown in FIG. 1A) surgically can be completed with a suture by reattaching the leaflet to a papillary muscle. Another technique would be a trans-apical reconnection of the flail leaflet similar to a technology developed by a company named NeoChord.


A different technique would be to access the right ventricle 16 via trans-femoral vein 18 threading a catheter 20 or catheters to the apex or bottom of the right ventricle 16 as shown in FIG. 1. The entry would start in the femoral vein 18 in the groin proceeding up through the inferior vena cava into the right atrium 24 through the tricuspid valve 22 to the bottom of the right ventricle 16. Piercing through the venous or right side of the heart in the interventricular septal wall 19 to access the left ventricle 26 a catheter 20 can be passed to turn upward pointing to the mitral valve 28 as shown in FIG. 2. From this access point in the left ventricle 26 the flail mitral leaflet can be sutured and tethered pulling it back into position and reattached with a grounding anchor in the right ventricle 16 or imbedding the anchor into the septal wall. The interventricular septal wall crossing technique could include the passing of a coaxial catheter 30 through the first access catheter 20 where the first access catheter 20 could act as a guide to direct the internal or second coaxial catheter 30 toward the flail mitral leaflet. Both first and second catheters 20, 30 could be steerable to position the distal tip direction to capture the margin of the mitral leaflet as shown in FIG. 3. A piercing needle could be passed to thread a suture through the mitral leaflet for reattachment or the leaflet to the lower chamber of the heart, into the septal wall or transvers the septal wall and anchor in the right ventricle. Threaded a tether through the mitral leaflet and back through the second internal catheter 30 and attached to the grounding anchor, the leaflet would be pulled into proper position replicating a chordal attachment that may have failed or broken. The attachment of the new suture to the grounding anchor could be achieved through a knot, sliding one-way stopper or other means to join the anchor and suture together. A single line attachment or a plurality of lines would allow the load to be shared or pulled in different force vectors moving the grounding point of the mitral leaflet in different directions. As shown in FIG. 3, a secondary atrial access could be achieved through the venous system superiorly to the mitral valve via trans-septal puncture to pass an additional catheter 32 into the left atrium for positioning above the flail leaflet. Achieving a second securement of the leaflet from above along with below would allow for positive positioning and suture attachment within the leaflet margin as viewed under echo and fluoroscopy. At the tip of each catheter could be a magnet 36, 34 to position the tips of each catheter 30, 32 relative to one another as shown in FIG. 4. The magnet 36, 34 could have a through-hole or central lumen to pass wires, suture 43 or other items longitudinally from one tip to another. A suture loop 41 would be passed through the mitral leaflet 27 and tethered back through the lower catheter 30 and attached to the anchor at the apex or intraventricular septal wall as shown in FIG. 4A.


The grounding plug or anchor 40 could be similar to an Amplatz device used for closing an ASD or another device to distribute forces to a larger area distributing the load throughout a larger surface area in the right ventricle or within the interventricular septal wall as shown in FIG. 5 Another means to secure the sutures within the right ventricle would be attach them to a pledget 73 or other pad to spread the load within the right ventricle. One alternative technique would be to imbed an internal anchor 42 within the tissue wall separating the left and right ventricle or interventricular septal wall tissue as shown in FIG. 5A. This internal anchors 50 of FIGS. 5B and 5AA could be delivered from above, or from the left atrium, through the septal access and passing through the mitral leaflet to connect the mitral leaflet to the suture 43 and into the septal wall between the right and left ventricle securing it to an internal structure such as an anchor to resist movement during the tensioning of the suture line. As shown in FIG. 5A, the intertal anchor can include barbs 80 and a suture hold 82. It may also be advantageous to extend a section of the anchor into the left atrium away from the septal wall to position the tangent point directly below the attachment point of the mitral leaflet. This would provide a direct line to the attachment points above and below without a torque or moment about the entry to the septal wall and not interfere with any other chordal structures or papillary muscles. A strain relief at the anchor exit may also prohibit fretting of the suture line as its cyclical loading may be an area of stress concentration. Also a coiled anchor 52 (see FIG. 5B) could be delivered from above with a trans-septal access through the mitral valve and into the apex of the heart or into the myocardial tissue as shown in FIG. 7. The coil 55 would allow a contact point connected to the suture line which is farther connected to the mitral leaflet. A plurality of connection points could also be added for additional support or to tether additional ruptured chords. A secondary adjustment could also occur by re-tethering the connection lines by winding, re-knotting or pulling the suture lines post implant procedure.


Access into the femoral vein could occur with a guidewire 70 measuring about 0.035 inches in diameter and about 180 centimeters in length. An introducer sheath could follow to provide a conduit to pass additional catheters in and out of the femoral access site as shown in FIG. 8. The catheter 72 could measuring about 10 to 24 French in diameter the introducer could be advanced into the femoral vein with a dilator to guide the tip without vessel trauma. The length of the catheter 72 could be about 100 centimeters in length. Advancing the device delivery catheter through this introducer sheath over the guidewire 72 could provide a radiopaque means for tracking the guidewire, introducer sheath and delivery catheter via live x-ray or fluoroscopy. Passed into the inferior vena cava and turning into the right atrium through the tricuspid valve, the catheter can follow the guidewire or be actively shaped or bent through a deflectable catheter at the handle via pull-wire or shaping system. Contrast dye injected into the heart can provide a road map to structural items within the heart. Aiming or steering the catheter and guidewire to the apex of the right ventricle and passing a needle or piercing tool to pass from the right ventricle to the left ventricle will provide access from the femoral vein to the left ventricle accessing the mitral valve.


An access pathway to the left atrium through a trans-septaL puncture can be completed by also via the femoral artery at the groin to advance a guidewire and catheter system in a similar manor as described above. This would allow for an above and below intimate contact of the mitral valve leaflets to secure and suture them back into proper positioning. The above-catheter from the left atrium and below—catheter from the left ventricle, via right ventricle, can locate and hold the position of the flail leaflet for suture piercing and tethering back into its proper position to coapt with the adjacent leaflet eliminating the mitral regurgitated blood flow. Piercing needles and strain relieving pledgets 75 could be used to pass suture 75 and distribute the local forces at the leaflet attachment site as shown in FIG. 6. Single or multiple passes through the leaflet will provide a duplication of the normal chorde providing normal leaflet motion. The suture material can be #4 or #5 pTFE, Silk or other common materials used in normal valve repair. The position of the suture would allow for normal left ventricle and mitral valve motion and freedom as the suture would pass in between the papillary muscles and connect to the flail leaflet at one end and into the right ventricle at the other end held by a strain relief in the right ventricle. Access from the jugular vein would also provide access into the vena cava and right ventricle and or access into the left atrium via trans-septal puncture as shown in FIG. 8. This jugular access would eliminate the first 180 degree turn up the femoral vein and into the right ventricle but is not a conventional access for most interventional cardiologist.


Catheters would be constructed of common polymers including nylon, Teflon, urethanes, and other commonly used materials having a proximal and distal end with a guidewire port through s The catheter curves needed would be pre-set, fixed or actively curved through differential forces transmitted via pull wires or tubes to bias one direction or another providing a column compression on one side of the catheter relative to the other. Column and tubular strength could be provided by imbedded coiled wires, braided with ribbon or round wire, laser cut tubes or skeletal structures to form a defined structure and or curve needed to gain access. Variable durometers, construction techniques are well known in the industry to allow for specific pushability, stiffness and curves needed to deliver. Coatings and surface treatments both internally and externally could aid in relative movement between vessel walls and between wires and other catheters. The tensioning means could be provided by a pull-wire extending from the distal end of the catheter to the handle of the proximal section. This pull wire could be activated by rotational screws translated into longitudinal forces pulling a connection to the distal end of the catheter. The overall length of the femoral catheter access would be about 100 cm in length and have a through lumen to accept a guidewire for positioning within the bodies vasculature. The overall length of the internal jugular catheter would be about 60 cm in length. Both catheters would be about 6-20 French in diameter with at least one lumen from the proximal distal end of the delivery system.


Access from the femoral vein will allow for catheterization through the tricuspid valve and into the right ventricle. At the apex of the right ventricle an access will be attained by advancing a needle or catheter in through the septal wall gaining access to the left ventricle. Use of a needle, ultrasonic or coring tool to pass a guidewire from right ventricle to left ventricle is the pathway and access route to repair the mitral valve. Once a needle and or guidewire can be advanced additional tools such as catheters can be utilized to repair the mitral valve. The septal wall can be over 1 centimeter in thickness so maintaining an access port may be achieved by a balloon dilatation, guide catheter or access conduit to pass tools and catheters through during the repair. A steerable sheath, catheter or conduit may allow an easier access direction to the specific area of the mitral valve for repair. Adjustments made rotationally and or angularly can be fixed or locked into position once optimal positioning is obtained. This can be achieved by a pre-shaped curve configuration whereas the catheter is curved down through the tricuspid valve and across the ventricular septal wall then pointing upward toward the mitral valve. This shape can be fixed or variable based upon patient needs and anatomy. Guidewires measuring about 0.035 inches in diameter and about 180 to 300 centimeters in length will allow for catheters to be advanced over and allow exchange of additional tools to be interchanged. Expandable dilators can be used expand areas where tight access is required or larger bore catheters are required. Catheter sizing may start from about 6 French to about 24 French in diameter and range from lengths including 90 centimeters to 160 centimeters. Construction of these catheters can be of normal polymers including nylon, polyurethane, polyethylene or other similar polymers. Braids, coils or laser cut tubes can be used within the catheter construction to better support inner diameters, shapes or curves required. These materials can also include stainless steel, Nitinol, Platinum or MP35N metallic suitable for catheter construction.


Nesting multiple catheters inside one another will provide for additional curves, movement, and translational freedoms. In one embodiment a larger catheter (24 French inner diameter) to access the apex of the right ventricle could be used to position a stable base from which to advance an inner catheter (18 French inner diameter) through the ventricular septaI wall and a third catheter could be advanced through this catheter measuring about 14 French inner diameter to advance into the left ventricle directing toward the mitral valve. These catheters would allow for multiple adjustments and angles for various anatomies. The ability to translate, rotate and lock position of each of these catheters together or independently will provide a stable platform to deliver repair tools to the valve. Locking means for each of these catheters nested inside one another can be achieved by an expansion via diameter change using a hydraulic pressure, a mechanical expansion via rotational means creating an eccentric lock or a longitudinal pull to create a differential diameter between the catheters. This push-pull translation could force the catheter to accordion creating a larger bump within one catheter.


Additionally, push pull wires could force the catheters into predetermined shapes and curves in single or multiple plains. By laser cutting a specific pattern into the catheter inner frame a shape can be forced by a pull wire reducing one side of the catheter length while collapsing the round column shape of the catheter creating a shape as determined by the laser cut element internal to the catheter. As an example, a slot could be cut into one side of the tube and a tension wire attached at the distal end of the tube. As tension is applied to the wire, a collapsing of the slotted side of the tube would result in curve or bias to the tubular element. These slots could also be complex shapes to lock the rotational angle into a pre-determined shape. This complex shape could be a chevron, angled cut, radiused shape or another detailed pattern to stop the collapsing of the tube at a predetermined radius. This pattern could also be rotated about the tube to create three-dimensional shapes and curves out of a single plane.


This patterning would be laser cut into the inner tube of the catheter and be constructed from a metallic or polymer and embedded into the wall of the catheter wall.


The first angular curve would be about 180 degrees changing the direction of the catheter from the femoral access through the tricuspid valve and directing toward the apex of the right ventricle. The second curve in this catheter would be about a 90 degree turn toward the ventricular septal wall making a “Shepard's Crook” shape. This 90 degree direction could be also attained with a second inner catheter passed through the first larger diameter catheter to direct the access through the ventricular septal wall. This would require a 90 degree curve to redirect the tip toward the septal wall. Once a penetration of the septaI wall is achieved another 90 degree curve would be required to direct the catheter toward the mitral valve. Between these two 90 degree curves and separation of about 1 to 2 centimeters is required to traverse the septal wall tissue. This straight section could be preshaped into the curve configuration and be actuated with a single pull wire or multiple pull wires. The preferred embodiment would utilize the first catheter to attain the 90 degree curve toward the ventricular septal wall.


The next inner catheter directed toward the mitral valve could be advanced toward the valve leaflets in the left ventricle. Directed and placed below the leaflet the catheter tip could locate the free margin of the mitral valve leaflet to secure a tether for a ruptured chord or flail leaflet repair. Single or multiple chords can emanate from a single access point or from separate locations along the valve leaflet. From above through a trans-septaI access a second catheter could located the top side of the leaflet along the same free margin of the leaflet. Locating these two catheters coaxially could be achieved through a magnetic tip that is built into the catheter or advanced through each central lumen of the catheters.


Locating these two catheters above and below the leaflet pinching one another with the leaflet sandwiched in between would allow for an access through the leaflet for chordal repair or tethering to secure through the lower access point originating from the right ventricle. The chordal repair could be a PTFE suture or another material suitable for permanent implantation. With the lower access point extending into the right ventricle an anchor could be located completely in the right ventricle or within the ventricular septal wall exposing only the replacement suture material in the left ventricle. Anchor designs can be similar to a barbed anchor with a single or plurality of barbs to engage the tissue, a plug to hold from the right ventricle side of the septal wall or a screw means to engage the tissue in the right or left ventricle. The attachment of the tissue anchor to the chordal leaflet attachment can be adjusted while monitoring the tension of the chord or the echo results live during or after the implantation of the chords and anchor system.

Claims
  • 1. A method of repairing a mitral valve of a patient's heart, the method comprising: advancing a first catheter through a right side of an interventricular septal wall to access a left ventricle and positioning a distal tip of the first catheter below a mitral valve leaflet;advancing a second catheter transeptally from a right atrium and into a left atrium and positioning a distal tip of the second catheter above the mitral valve leaflet;passing a suture from one of the catheters to another catheter through the mitral valve leaflet; andattaching the suture to a ventricular anchor secured to a tissue in the left ventricle, the ventricular anchor coupled to the suture.
  • 2. The method of claim 1, wherein the ventricular anchor is attached to an apex of the left ventricle.
  • 3. The method of claim 1, wherein the ventricular anchor is attached to the interventricular septal wall.
  • 4. The method of claim 1, further comprising passing a piercing tool through the first catheter and through the mitral valve leaflet.
  • 5. The method of claim 1, further comprising holding a position of the mitral valve leaflet with the first catheter and the second catheter.
  • 6. The method of claim 1, further comprising passing the suture through the mitral valve leaflet multiple times.
  • 7. The method of claim 1, further comprising passing multiple sutures through the mitral valve leaflet multiple times.
  • 8. The method of claim 1, wherein the distal tip of the first catheter and the distal tip of the second catheter includes magnets.
  • 9. The method of claim 1, wherein a pledget is attached to the suture to spread a load applied to the mitral valve leaflet.
  • 10. A method of repairing a mitral valve of a patient's heart, the method comprising: advancing a first catheter through a septal wall to provide access to a position below a mitral valve leaflet;advancing a second catheter to a position above the mitral valve leaflet;passing a suture through the mitral valve leaflet such that the suture extends between the first catheter and the second catheter; andattaching the suture to a ventricular anchor secured to a tissue in a left ventricle, the ventricular anchor coupled to the suture;wherein a distal tip of the first catheter and a distal tip of the second catheter both include magnets.
INCORPORATION BY REFERENCE TO ANY PRIORITY APPLICATIONS

This application is a continuation of U.S. application Ser. No. 16/024,439, filed Jun. 29, 2018, which is a continuation of PCT Patent Application No. PCT/US2016/069567, filed Dec. 30, 2016, which claims a priority benefit to U.S. Provisional Application No. 62/383,338, filed Sep. 2, 2016 and U.S. Provisional Application No. 62/273,300, filed Dec. 30, 2015, the entire disclosure of each these non-provisional and these provisional applications are hereby incorporated by reference herein for all purposes in their entireties and should be considered a part of this specification.

US Referenced Citations (273)
Number Name Date Kind
4677065 Buchbjerg et al. Jun 1987 A
4969870 Kramer et al. Nov 1990 A
5329923 Lundquist Jul 1994 A
5456708 Doan et al. Oct 1995 A
5674217 Wahlstrom et al. Oct 1997 A
6269819 Oz Aug 2001 B1
6458107 Ockuly Oct 2002 B1
6461366 Seguin Oct 2002 B1
6569105 Kortenbach et al. May 2003 B1
6626930 Allen et al. Sep 2003 B1
6629534 St. Goar et al. Oct 2003 B1
6743239 Kuehn et al. Jun 2004 B1
6752813 Goldfarb et al. Jun 2004 B2
6770083 Seguin Aug 2004 B2
6840246 Downing Jan 2005 B2
6978176 Lattouf Dec 2005 B2
7048754 Martin et al. May 2006 B2
7083628 Bachman Aug 2006 B2
7191545 Yi Mar 2007 B2
7226467 Lucatero et al. Jun 2007 B2
7288097 Seguin Oct 2007 B2
7464712 Oz et al. Dec 2008 B2
7563267 Goldfarb et al. Jul 2009 B2
7604646 Goldfarb et al. Oct 2009 B2
7608091 Goldfarb et al. Oct 2009 B2
7632308 Loulmet Dec 2009 B2
7635386 Gammie Dec 2009 B1
7637903 Lentz et al. Dec 2009 B2
7655015 Goldfarb et al. Feb 2010 B2
7666204 Thornton et al. Feb 2010 B2
7682369 Seguin Mar 2010 B2
7736388 Goldfarb et al. Jun 2010 B2
7871368 Zollinger et al. Jan 2011 B2
7871433 Lattouf Jan 2011 B2
7887552 Bachman Feb 2011 B2
7914515 Heideman et al. Mar 2011 B2
7914545 Ek Mar 2011 B2
8075570 Bolduc et al. Dec 2011 B2
8100923 Paraschac et al. Jan 2012 B2
8172872 Osypka May 2012 B2
8241304 Bachman Aug 2012 B2
8252050 Maisano et al. Aug 2012 B2
8273054 St. Germain et al. Sep 2012 B2
8303622 Alkhatib Nov 2012 B2
8382829 Call et al. Feb 2013 B1
8394113 Wei et al. Mar 2013 B2
8409273 Thornton et al. Apr 2013 B2
8465500 Speziali Jun 2013 B2
8475472 Bachman Jul 2013 B2
8475525 Maisano et al. Jul 2013 B2
8480730 Maurer et al. Jul 2013 B2
8535339 Levin et al. Sep 2013 B2
8545551 Loulmet Oct 2013 B2
8545553 Zipory et al. Oct 2013 B2
8603066 Heidman et al. Dec 2013 B2
8690939 Miller et al. Apr 2014 B2
8718794 Helland May 2014 B2
8740940 Maahs et al. Jun 2014 B2
8778016 Janovsky et al. Jul 2014 B2
8814824 Kauphusman et al. Aug 2014 B2
8852213 Gammie et al. Oct 2014 B2
8940042 Miller et al. Jan 2015 B2
8945211 Sugimoto Feb 2015 B2
8951285 Sugimoto et al. Feb 2015 B2
8951286 Sugimoto et al. Feb 2015 B2
8961594 Maisano et al. Feb 2015 B2
8961596 Maisano et al. Feb 2015 B2
9011520 Miller et al. Apr 2015 B2
9023065 Bolduc et al. May 2015 B2
9050187 Sugimoto et al. Jun 2015 B2
9131939 Call et al. Sep 2015 B1
9180007 Reich et al. Nov 2015 B2
9198649 Karapetian et al. Dec 2015 B2
9241702 Maisano et al. Jan 2016 B2
9259218 Robinson Feb 2016 B2
9277994 Miller et al. Mar 2016 B2
9307980 Gilmore et al. Apr 2016 B2
9314242 Bachman Apr 2016 B2
9474606 Zipory et al. Oct 2016 B2
9492264 Fifer et al. Nov 2016 B2
9572667 Solem Feb 2017 B2
9579097 Shluzas Feb 2017 B2
9636205 Lee et al. May 2017 B2
9636224 Zipory et al. May 2017 B2
9668860 Kudlik et al. Jun 2017 B2
9681864 Gammie et al. Jun 2017 B1
9681964 MacKenzie Jun 2017 B2
9693865 Gilmore et al. Jul 2017 B2
9724195 Goodwin et al. Aug 2017 B2
9750493 Robinson et al. Sep 2017 B2
9788948 Gilmore et al. Oct 2017 B2
9801720 Gilmore et al. Oct 2017 B2
9814454 Sugimoto et al. Nov 2017 B2
9877833 Bishop et al. Jan 2018 B1
9907547 Gilmore et al. Mar 2018 B2
9907681 Tobis et al. Mar 2018 B2
10022114 Gilmore et al. Jul 2018 B2
10039643 Gilmore et al. Aug 2018 B2
10039644 Navia et al. Aug 2018 B2
10052095 Gilmore et al. Aug 2018 B2
10058323 Maisano Aug 2018 B2
10076327 Ellis et al. Sep 2018 B2
10076658 Hastings et al. Sep 2018 B2
10130791 Heideman et al. Nov 2018 B2
10159571 de Canniere Dec 2018 B2
10206673 Maisano et al. Feb 2019 B2
10231727 Sutherland et al. Mar 2019 B2
10238491 Tobis Mar 2019 B2
10285686 Gammie et al. May 2019 B2
10376266 Herman et al. Aug 2019 B2
10543090 Griswold et al. Jan 2020 B2
10548733 Purcell et al. Feb 2020 B2
10595994 Christianson et al. Mar 2020 B1
10617523 Purcell et al. Apr 2020 B2
10624743 Keidar et al. Apr 2020 B2
10660753 Pham et al. May 2020 B2
10667910 Bishop et al. Jun 2020 B2
10675150 Bishop et al. Jun 2020 B2
10682230 Bishop et al. Jun 2020 B2
10925731 Bishop et al. Feb 2021 B2
11083580 Purcell et al. Aug 2021 B2
20030083674 Gibbens May 2003 A1
20030105519 Fasol et al. Jun 2003 A1
20030120341 Shennib et al. Jun 2003 A1
20030130598 Manning et al. Jul 2003 A1
20040044350 Martin et al. Mar 2004 A1
20040044365 Bachman Mar 2004 A1
20040049207 Goldfarb et al. Mar 2004 A1
20040073216 Lieberman Apr 2004 A1
20040091600 Salome et al. May 2004 A1
20040097979 Svanidze et al. May 2004 A1
20040162568 Saadat et al. Aug 2004 A1
20040172046 Hlavka et al. Sep 2004 A1
20050096694 Lee May 2005 A1
20050119735 Spence et al. Jun 2005 A1
20050177132 Lentz et al. Aug 2005 A1
20050177180 Kaganov et al. Aug 2005 A1
20050251210 Westra et al. Nov 2005 A1
20070010857 Sugimoto et al. Jan 2007 A1
20070038230 Stone et al. Feb 2007 A1
20070038293 St. Goar et al. Feb 2007 A1
20070118151 Davidson May 2007 A1
20070123979 Perier et al. May 2007 A1
20070219565 Saadat Sep 2007 A1
20080177281 Weitzner et al. Jul 2008 A1
20080177304 Westra et al. Jul 2008 A1
20080195126 Solem Aug 2008 A1
20080226810 Passe et al. Sep 2008 A1
20080228165 Spence et al. Sep 2008 A1
20080228223 Alkhatib Sep 2008 A1
20080288061 Maurer et al. Nov 2008 A1
20080294188 Appling et al. Nov 2008 A1
20090043153 Zollinger et al. Feb 2009 A1
20090069847 Hashiba et al. Mar 2009 A1
20090082828 Ostroff Mar 2009 A1
20090088837 Gillinov et al. Apr 2009 A1
20090287304 Dahlgren et al. Nov 2009 A1
20090312773 Cabrera Dec 2009 A1
20090312790 Forsberg et al. Dec 2009 A1
20100023118 Medlock et al. Jan 2010 A1
20100042147 Janovsky Feb 2010 A1
20100161041 Maisano Jun 2010 A1
20100161042 Maisano et al. Jun 2010 A1
20100161043 Maisano et al. Jun 2010 A1
20100249919 Gillinov et al. Sep 2010 A1
20100280604 Zipory et al. Nov 2010 A1
20110011917 Loulmet Jan 2011 A1
20110022083 DiMatteo et al. Jan 2011 A1
20110040326 Wei Feb 2011 A1
20110060407 Ketai et al. Mar 2011 A1
20110106245 Miller et al. May 2011 A1
20110257581 Koziczynski et al. Oct 2011 A1
20110301698 Miller et al. Dec 2011 A1
20120065464 Ellis et al. Mar 2012 A1
20120095505 Shluzas Apr 2012 A1
20120116418 Belson et al. May 2012 A1
20120116489 Khairkhahan et al. May 2012 A1
20120158021 Morrill Jun 2012 A1
20120172915 Fifer et al. Jul 2012 A1
20130035757 Zentgraf et al. Feb 2013 A1
20130046380 Maisano et al. Feb 2013 A1
20130096672 Reich et al. Apr 2013 A1
20130158567 Levin et al. Jun 2013 A1
20130190741 Moll et al. Jul 2013 A1
20130197575 Karapetian et al. Aug 2013 A1
20130197577 Wolf et al. Aug 2013 A1
20130197578 Gregoire et al. Aug 2013 A1
20130253639 Alkhatib Sep 2013 A1
20140031926 Kudlik et al. Jan 2014 A1
20140142687 De Canniere et al. May 2014 A1
20140142689 De Canniere et al. May 2014 A1
20140243877 Lee et al. Aug 2014 A9
20140243963 Sheps et al. Aug 2014 A1
20140350417 Van Bladel et al. Nov 2014 A1
20150032127 Gammie et al. Jan 2015 A1
20150119979 Maisano et al. Apr 2015 A1
20150182255 Shivkumar Jul 2015 A1
20150230919 Chau et al. Aug 2015 A1
20150250590 Gries et al. Sep 2015 A1
20150272586 Herman et al. Oct 2015 A1
20150313620 Suri Nov 2015 A1
20150342737 Biancucci et al. Dec 2015 A1
20150359632 Navia et al. Dec 2015 A1
20160058557 Reich et al. Mar 2016 A1
20160143737 Zentgraf et al. May 2016 A1
20160174964 Tobis Jun 2016 A1
20160192925 Bachman Jul 2016 A1
20160228117 Borden Aug 2016 A1
20160240941 Stavrianoudakis Aug 2016 A1
20160256269 Cahalane et al. Sep 2016 A1
20160262741 Gilmore et al. Sep 2016 A1
20160310701 Pai Oct 2016 A1
20160354082 Oz et al. Dec 2016 A1
20160367367 Maisano et al. Dec 2016 A1
20170042658 Lee et al. Feb 2017 A1
20170043120 Heideman et al. Feb 2017 A1
20170079797 Maisano et al. Mar 2017 A1
20170086975 Gilmore et al. Mar 2017 A1
20170119368 Solem May 2017 A1
20170135817 Tylis et al. May 2017 A1
20170156719 Tobis Jun 2017 A1
20170156861 Longoria et al. Jun 2017 A1
20170202657 Lee et al. Jul 2017 A1
20170202669 Schaffner et al. Jul 2017 A1
20170252032 Hiorth et al. Sep 2017 A1
20170258464 Gammie et al. Sep 2017 A1
20170258588 Zipory et al. Sep 2017 A1
20170258594 Gilmore et al. Sep 2017 A1
20170273681 Gilmore et al. Sep 2017 A1
20170304051 Tobis et al. Oct 2017 A1
20170340433 Berra et al. Nov 2017 A1
20170340443 Stearns et al. Nov 2017 A1
20180064535 Gilmore et al. Mar 2018 A1
20180185153 Bishop et al. Jul 2018 A1
20180185179 Murphy et al. Jul 2018 A1
20180206992 Brown Jul 2018 A1
20180221148 Guidotti et al. Aug 2018 A1
20180249993 Denti et al. Sep 2018 A1
20180289480 D'ambra et al. Oct 2018 A1
20180303614 Schaffner et al. Oct 2018 A1
20180311007 Tyler, II et al. Nov 2018 A1
20180318079 Patel et al. Nov 2018 A1
20180318083 Bolling et al. Nov 2018 A1
20180344311 Gilmore et al. Dec 2018 A1
20180353297 Griffin Dec 2018 A1
20180360439 Niland et al. Dec 2018 A1
20190000624 Wilson et al. Jan 2019 A1
20190015205 Rajagopal et al. Jan 2019 A1
20190069891 Gilmore et al. Mar 2019 A1
20190083085 Gilmore et al. Mar 2019 A1
20190105027 Gilmore et al. Apr 2019 A1
20190117401 Cortez, Jr. et al. Apr 2019 A1
20190151090 Gross et al. May 2019 A1
20190175345 Schaffner et al. Jun 2019 A1
20190175346 Schaffner et al. Jun 2019 A1
20190183480 Hiorth et al. Jun 2019 A1
20190183648 Trapp et al. Jun 2019 A1
20190216599 Alkhatib Jul 2019 A1
20190216601 Purcell et al. Jul 2019 A1
20190240023 Spence et al. Aug 2019 A1
20190314155 Franklin et al. Oct 2019 A1
20190328530 McDaniel et al. Oct 2019 A1
20190365539 Rabito et al. Dec 2019 A1
20190380699 Bak-Boychuk et al. Dec 2019 A1
20200155798 Yang et al. May 2020 A1
20200297489 Bishop et al. Sep 2020 A1
20200330228 Anderson et al. Oct 2020 A1
20200345496 Bishop et al. Nov 2020 A1
20200390554 Pham et al. Dec 2020 A1
20210186699 Bishop et al. Jun 2021 A1
20210213259 Giasolli et al. Jul 2021 A1
20220338990 Hammill et al. Oct 2022 A1
20220339437 Sorajja Oct 2022 A1
Foreign Referenced Citations (55)
Number Date Country
101495049 Jul 2009 CN
101553190 Oct 2009 CN
101184454 Oct 2010 CN
101902975 Dec 2010 CN
103491901 Jan 2014 CN
103635160 Mar 2014 CN
103813757 May 2014 CN
103889345 Jun 2014 CN
104000625 Aug 2014 CN
104582637 Apr 2015 CN
105555229 May 2016 CN
107569301 Jan 2018 CN
0476047 Mar 1992 EP
1400537 Mar 2004 EP
1 898 802 Sep 2015 EP
2 979 647 Feb 2016 EP
3562410 Nov 2019 EP
2889416 Feb 2007 FR
2009-500105 Jan 2009 JP
2014-523282 Sep 2014 JP
2019-500998 Jan 2019 JP
2219853 Dec 2003 RU
WO 2007061834 May 2007 WO
WO 2007100268 Sep 2007 WO
WO 2008005747 Jan 2008 WO
WO 2010128502 Nov 2010 WO
WO 2012040865 Apr 2012 WO
2012167120 Dec 2012 WO
WO 2013179295 Dec 2013 WO
WO 2014134185 Sep 2014 WO
WO 2017066888 Apr 2017 WO
WO 2017066889 Apr 2017 WO
WO 2017066890 Apr 2017 WO
WO 2017117560 Jul 2017 WO
WO 2018035378 Feb 2018 WO
WO 2018126188 Jul 2018 WO
WO 2018148324 Aug 2018 WO
WO 2018148364 Aug 2018 WO
WO 2018160456 Sep 2018 WO
WO 2018227048 Dec 2018 WO
WO 2019013994 Jan 2019 WO
WO 2019074815 Apr 2019 WO
WO 2019177909 Sep 2019 WO
WO 2019195860 Oct 2019 WO
WO 2019231744 Dec 2019 WO
WO 2019236654 Dec 2019 WO
WO 2020106705 May 2020 WO
WO 2020109594 Jun 2020 WO
WO 2020109596 Jun 2020 WO
WO 2020109599 Jun 2020 WO
WO 2020123719 Jun 2020 WO
WO 2020219281 Oct 2020 WO
WO 2020256853 Dec 2020 WO
WO 2021257278 Dec 2021 WO
WO 2022232070 Nov 2022 WO
Non-Patent Literature Citations (9)
Entry
Carpentier, M.D., Alain, “Cardiac Valve Surgery—the ‘French Correction’”, The Journal of Thoracic and Cardiovascular Surgery, Sep. 1983, vol. 86, No. 3, pp. 323-337.
Júnior, Francisco Gregori et al., “Surgical Repair of Chordae Tendineae Rupture After Degenerative Valvular Regurgitation Using Standardized Bovine Pericardium”, Revista Brasileira de Cirurgia Cardiovascular, Jan. 2013, vol. 28, No. 1, pp. 36-46.
Kobayashi et al., “Ten Year Experience of Chordal Replacement with Expanded Polytetrafluoroethylene in Mitral Valve Repair”, Circulation, American Heart Association, Nov. 7, 2000, pp. III-30-34.
Shikata et al., “Repair of Congenitally Absent Chordae in a Tricuspid Valve Leaflet with Hypoplastic Papillary Muscle Using Artificial Chordae”, J Card Surg, 25:737-739 (2010).
International Search Report and Written Opinion received in PCT Application No. PCT/US2016/069567, dated Mar. 23, 2017 in 13 pages.
International Preliminary Report on Patentability received in PCT Application No. PCT/US2016/069567, dated Jul. 12, 2018 in 6 pages.
International Search Report and Written Opinion received in PCT Application No. PCT/US2017/069046, dated Jun. 14, 2018 in 10 pages.
International Search Report and Written Opinion received in PCT Application No. PCT/US2019/021480, dated Jul. 15, 2019 in 12 pages.
International Search Report and Written Opinion received in PCT Application No. PCT/US2019/065814, dated Apr. 1, 2020 in 14 pages.
Related Publications (1)
Number Date Country
20230397992 A1 Dec 2023 US
Provisional Applications (2)
Number Date Country
62383338 Sep 2016 US
62273300 Dec 2015 US
Continuations (2)
Number Date Country
Parent 16024439 Jun 2018 US
Child 18335589 US
Parent PCT/US2016/069567 Dec 2016 WO
Child 16024439 US